These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25556152)

  • 41. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
    Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
    Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
    Vilar L; Czepielewsk MA; Naves LA; Rollin GA; Casulari LA; Coelho CE
    Endocr Pract; 2007; 13(4):396-402. PubMed ID: 17669717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Biology of Pituitary Adenomas.
    Faltermeier CM; Magill ST; Blevins LS; Aghi MK
    Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of irradiation therapy and inhibiting drugs on the pituitary and its adenomas].
    Saeger W
    Pathologe; 2006 Feb; 27(1):57-60. PubMed ID: 16362259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
    Fedele M; De Martino I; Pivonello R; Ciarmiello A; Del Basso De Caro ML; Visone R; Palmieri D; Pierantoni GM; Arra C; Schmid HA; Hofland L; Lombardi G; Colao A; Fusco A
    Clin Cancer Res; 2007 May; 13(9):2738-44. PubMed ID: 17473207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical treatment of functional pituitary tumors.
    Vance ML
    Neurosurg Clin N Am; 2003 Jan; 14(1):81-7. PubMed ID: 12690980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.
    Ceccato F; Lombardi G; Manara R; Emanuelli E; Denaro L; Milanese L; Gardiman MP; Bertorelle R; Scanarini M; D'Avella D; Occhi G; Boscaro M; Zagonel V; Scaroni C
    J Neurooncol; 2015 Mar; 122(1):189-96. PubMed ID: 25555563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric pituitary adenomas.
    Walz PC; Drapeau A; Shaikhouni A; Eide J; Rugino AJ; Mohyeldin A; Carrau R; Prevedello D
    Childs Nerv Syst; 2019 Nov; 35(11):2107-2118. PubMed ID: 31302729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current status and future directions of pharmacological therapy for acromegaly.
    Mercado M; Espinosa E; Ramírez C
    Minerva Endocrinol; 2016 Sep; 41(3):351-65. PubMed ID: 26485036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
    Melmed S; Sternberg R; Cook D; Klibanski A; Chanson P; Bonert V; Vance ML; Rhew D; Kleinberg D; Barkan A
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4405-10. PubMed ID: 15827109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
    Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
    Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].
    Wiesner TD; Trantakis C; Meixensberger J; Koch CA; Zimmer C; Paschke R
    Med Klin (Munich); 2005 Apr; 100(4):173-9. PubMed ID: 15834525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pituitary lactotroph adenomas resistant to dopamine agonist treatment: histological and immunohistochemical characteristics].
    Fedorova NS; Abrosimov AY; Dzeranova LK; Pigarova EA; Dedov II
    Arkh Patol; 2018; 80(3):34-39. PubMed ID: 29927438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
    Pawlikowski M
    Folia Histochem Cytobiol; 2010 Sep; 48(3):394-7. PubMed ID: 21071344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [TSH-secreting pituitary adenomas].
    Beckers A; Hennen G; Reznik M; Thibaut A; Stevenaert A
    Rev Med Liege; 1988 May; 43(10):396-402. PubMed ID: 2899901
    [No Abstract]   [Full Text] [Related]  

  • 59. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature.
    Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C
    Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.